Drug responseDRUG → PROTEIN-MSCell line8-(3-chloro-4-methoxy-phenethyl)-4-(3,5-dimethyl-isoxazol-4-yl)-9-(2-(morpholin-4-yl)-propyl)-7,9-diaza-bicyclo[4.3.0]nona-1(6),2,4,7-tetraene
Across CCLE and GDSC cell-line panels, response to SGC-CBP30 is significantly associated with the protein abundance of multiple proteins, with OVARY cell lines showing a particularly strong set of associations.
The most reproducible SGC-CBP30 response-associated proteins across cancer lineages are LMNA, EEF1E1, and OGDH, each associated with drug response in up to 8 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, SGC-CBP30 response versus LMNA protein abundance in OVARY (Pearson r = -0.42).
Protein abundance biomarkers of SGC-CBP30 response
Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.